(Q46749470)

English

Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

Konstantinos Dimopoulos

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

Philippe Gabriel Steg

13

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

object named as

Carlo Di Mario

1

0 references

2

object named as

Dariusz Dudek

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

Krzysztof Żmudka

11

object named as

Krzysztof Zmudka

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

Andrzej Ochała

10

object named as

Andrzej Ochala

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

Achille Gaspardone

9

object named as

Achille Gaspardone

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

author name string

Federico Piscione

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

Waldemar Mielecki

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

Stefano Savonitto

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

Ernesto Murena

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

Antonio Manari

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

Leonardo Bolognese

12

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

Marcus Flather

14

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators

15

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

language of work or name

0 references

publication date

1 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

371

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

9612

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

559-568

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

Management of acute myocardial infarction in patients presenting with ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategies for reducing the door-to-balloon time in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary intervention for persistent occlusion after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Facilitated angioplasty: paradise lost

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Time to treatment in primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction Dichotomous response as a function of age in the GUSTO V trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of transradial vs. transfemoral approach in the treatment of acute myocardial infarction with primary angioplasty and abciximab

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960268-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(08)60268-8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18280326

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46749470&oldid=2129793991"